参考文献/References:
［1］ 中华人民共和国国家卫生健康委员会.新型冠状病毒肺炎诊疗方案（试行第七版）［EB/OL］.（2020-03-04）［2020-03-04］.http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe 4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce 964.pdf.
［2］ 中华人民共和国国家卫生健康委员会.中华人民共和国国家卫生健康委员会公告2020年第1号［EB/OL］.（2020-01-20）［2020-02-28］.http://www.nhc.gov.cn/jkj/s7916/202001/44a 3b8245e8049d2837a4f27529cd386.shtml.
［3］ GORBALENYA A E,BAKER S C,BARIC R S,et al,Severe acute respiratory syndrome-related coronavirus:the species and its viruses:a statement of the Coronavirus Study Group［EB/OL］.（2020-02-07）［2020-02-28］.https://www.biorxiv.org/content/10.1101/2020.02.07.937862v1.full.pdf.
［4］ FEHR A R,PERLMAN S.Coronaviruses:an overview of their replication and pathogenesis［J］.Methods Mol Biol,2015,1282:1-23.
［5］ ZHOU P,YANG X L,WANG X G,et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin［J］.Nature,2020.DOI:10.1038/s41586-020-2012-7.［Epub ahead of print］.
［6］ CHEN Y,LIU Q,GUO D.Emerging coronaviruses:genome structure,replication,and pathogenesis［J］.J Med Virol,2020,92(4):418-423.
［7］ XU X,CHEN P,WANG J,et al.Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission［J］.Sci China Life Sci,2020,63(3):457-460.
［8］ JI W,WANG W,ZHAO X,et al.Cross-species transmission of the newly identified coronavirus 2019-nCoV［J］.J Med Virol,2020,92(4):433-440.
［9］ LIU Z,XIAO X,WEI X,et al.Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2［J］.J Med Virol,2020.DOI:10.1002/jmv.25726.［Epub ahead of print］.
［10］ 世界卫生组织.关于新型冠状病毒（2019-nCoV）疫情的《国际卫生条例（2005）》突发事件委员会会议的声明［EB/OL］.（2020-01-23）［2020-01-25］.https://www.who.int/zh/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).
［11］ TIPNIS S R,HOOPER N M,HYDE R,et al.A human homolog of angiotensin-converting enzyme.Cloning and functional expression as a captopril-insensitive carboxypeptidase［J］.J Biol Chem,2000,275(43):33238-33243.
［12］ 徐凯进，蔡洪流，沈毅弘，等.2019冠状病毒病（COVID-19）诊疗浙江经验［J］.浙江大学学报（医学版），2020，49（1）：9-20.
［13］ XIA J,LU G L,LU J,et al.Towards an effective mRNA vaccine against 2019-nCoV:demonstration of virus-like particles expressed from a modified mRNA cocktail［EB/OL］.（2020-02-25）［2020-02-28］.http://biotech.chinaxiv.org/abs/202002.00070serverID=2.
［14］ LI W H,MOORE M J,VASILIEVA N,et al.Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus［J］.Nature,2003,426(27):450-454.
［15］ HAMMING I,TIMENS W,BULTHUIS M L,et al.Tissue distribution of ACE2 protein,the functional receptor for SARS coronavirus.A first step in understanding SARS pathogenesis［J］.J Pathol,2004,203(2):631-637.
［16］ KUBA K,IMAI Y,RAO S,et al.A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury［J］.Nat Med,2005,11(8):875-879.
［17］ IMAI Y,KUBA K,OHTO-NAKANISHI T,et al.Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis［J］.Circ J,2010,74(3):405-410.
［18］ PEIRIS J S,CHU M,CHENG V C,et al.Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia:a prospective study［J］.Lancet,2003,361(9371):1767-1772.
［19］ BINNIE A,TSANG J L,DOS SANTOS C C.Biomarkers in acute respiratory distress syndrome［J］.Curr Opin Crit Care,2014,20(1):47-55.
［20］ KONG S L,CHUI P,LIM B,et al.Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients［J］.Virus Res,2009,145(2):260-269.
［21］ SNIJDER E J,VAN DER MEER Y,ZEVENHOVEN-DOBBE J,et al.Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex［J］.J Virol,2006,80(12):5927-5940.
［22］ WATHELET M G,ORR M,FRIEMAN M B,et al.Severe acute respiratory syndrome coronavirus evades antiviral signaling:role of nsp1 and rational design of an attenuated strain［J］.J Virol,2007,81(21):11620-11633.
［23］ KOPECKY-BROMBERG S A,MARTINEZ-SOBRIDO L,FRIEMAN M,et al.Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b,ORF 6,and nucleocapsid proteins function as interferon antagonists［J］.J Virol,2007,81(2):548-557.
［24］ IMAI Y,KUBA K,RAO S,et al.Angiotensin-converting enzyme 2 protects from severe acute lung failure［J］.Nature,2005,436(7047):112-116.
［25］ WANG M,CAO R,ZHANG L,et al.Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro［J］.Cell Res,2020.DOI:10.1038/s41422-020-0282-0.［Epub ahead of print］.